
Lakefront Biotherapeutics launches new €50M share buyback after completing initial program
Lakefront Biotherapeutics has started a new €50 million share buyback program following the completion of its initial €50 million program, in which it repurchased about 1.99 million shares. The new program, running until March 31, 2027, aims to enhan...





